合計 50 件の最近のインサイダー取引記録が記録されています Larimar Therapeutics, Inc. (LRMR), 内訳は 47 件の買い および 0 件の売り. インサイダー買い総額は $34.99M インサイダー売り総額は RSU アワード.
最近活動のある主要インサイダーには Sherman Jeffrey W, Thomas Frank E, Flynn James E. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — LRMR
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-02-27 |
Sherman Jeffrey W |
Director |
情報に基づく買い |
5,000 |
$5.00 |
$25K |
5,000 |
| 2026-02-27 |
Thomas Frank E |
Director |
情報に基づく買い |
5,000 |
$5.00 |
$25K |
7,000 |
| 2026-02-27 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
情報に基づく買い |
2,000,000 |
$5.00 |
$10M |
6,207,982 |
| 2026-02-27 |
Hamilton Thomas Edward |
Director |
情報に基づく買い |
100,000 |
$5.00 |
$500K |
664,798 |
| 2026-01-26 |
Celano Michael |
Chief Financial Officer |
RSU 付与（制限付株式） |
37,604 |
- |
- |
215,785 |
| 2026-01-26 |
Ben-maimon Carole |
President and CEO |
RSU 付与（制限付株式） |
100,100 |
- |
- |
368,276 |
| 2026-01-26 |
Clayton Russell |
Chief Medical Officer |
RSU 付与（制限付株式） |
25,637 |
- |
- |
71,443 |
| 2026-01-26 |
Shankar Gopi |
Chief Development Officer |
RSU 付与（制限付株式） |
25,637 |
- |
- |
76,443 |
| 2025-07-31 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
情報に基づく買い |
2,599,932 |
$3.20 |
$8.32M |
7,321,129 |
| 2025-05-13 |
Leff Jonathan S |
Director |
RSU 付与（制限付株式） |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Sherman Jeffrey W |
Director |
RSU 付与（制限付株式） |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Thomas Frank E |
Director |
RSU 付与（制限付株式） |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Truitt Joseph |
Director |
RSU 付与（制限付株式） |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Hamilton Thomas Edward |
Director |
RSU 付与（制限付株式） |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-05-13 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
RSU 付与（制限付株式） |
19,000 |
$1.88 |
$35.63K |
19,000 |
| 2025-01-22 |
Celano Michael |
Chief Financial Officer |
RSU 付与（制限付株式） |
34,185 |
- |
- |
178,181 |
| 2025-01-22 |
Ben-maimon Carole |
President and CEO |
RSU 付与（制限付株式） |
91,000 |
- |
- |
387,208 |
| 2025-01-22 |
Clayton Russell |
Chief Medical Officer |
RSU 付与（制限付株式） |
23,306 |
- |
- |
45,806 |
| 2025-01-22 |
Shankar Gopi |
Chief Development Officer |
RSU 付与（制限付株式） |
23,306 |
- |
- |
50,806 |
| 2024-05-29 |
Leff Jonathan S |
Director |
RSU 付与（制限付株式） |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Sherman Jeffrey W |
Director |
RSU 付与（制限付株式） |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Thomas Frank E |
Director |
RSU 付与（制限付株式） |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Truitt Joseph |
Director |
RSU 付与（制限付株式） |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Hamilton Thomas Edward |
Director |
RSU 付与（制限付株式） |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-05-29 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
RSU 付与（制限付株式） |
19,000 |
$7.07 |
$134.33K |
19,000 |
| 2024-02-16 |
Flynn James E |
10 Percent Owner, Other: * Director By Deputization |
情報に基づく買い |
1,430,205 |
$8.74 |
$12.5M |
4,207,982 |
| 2024-02-16 |
Hamilton Thomas Edward |
Director |
情報に基づく買い |
57,208 |
$8.74 |
$500K |
564,798 |
| 2024-02-14 |
Thomas Frank E |
Director |
情報に基づく買い |
2,000 |
$11.00 |
$22K |
2,000 |
| 2024-01-17 |
Celano Michael |
Chief Financial Officer |
RSU 付与（制限付株式） |
31,250 |
- |
- |
143,996 |
| 2024-01-17 |
Ben-maimon Carole |
President and CEO |
RSU 付与（制限付株式） |
66,125 |
- |
- |
332,954 |
| 2024-01-17 |
Clayton Russell |
Chief Medical Officer |
RSU 付与（制限付株式） |
22,500 |
- |
- |
22,500 |
| 2024-01-17 |
Shankar Gopi |
Chief Development Officer |
RSU 付与（制限付株式） |
22,500 |
- |
- |
27,500 |
| 2023-12-07 |
Shankar Gopi |
Chief Development Officer |
情報に基づく買い |
5,000 |
$3.73 |
$18.66K |
5,000 |
| 2023-10-03 |
Sherman Jeffrey W |
Director |
不明 |
- |
- |
- |
- |
| 2023-10-03 |
Sherman Jeffrey W |
Director |
RSU 付与（制限付株式） |
16,600 |
$3.56 |
$59.01K |
16,600 |
| 2023-07-17 |
Clayton Russell |
Officer |
不明 |
- |
- |
- |
- |
| 2023-07-17 |
Clayton Russell |
Chief Medical Officer |
RSU 付与（制限付株式） |
180,000 |
$3.22 |
$579.6K |
180,000 |
| 2023-05-17 |
Celano Michael |
Chief Financial Officer |
情報に基づく買い |
5,000 |
$3.73 |
$18.63K |
112,746 |
| 2023-05-17 |
Truitt Joseph |
Director |
情報に基づく買い |
2,750 |
$3.73 |
$10.26K |
2,750 |
| 2023-05-17 |
Ben-maimon Carole |
President and CEO |
情報に基づく買い |
5,000 |
$3.71 |
$18.53K |
266,829 |
| 2023-05-09 |
Leff Jonathan S |
Director |
RSU 付与（制限付株式） |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Thomas Frank E |
Director |
RSU 付与（制限付株式） |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Flynn James E |
10 Percent Owner |
RSU 付与（制限付株式） |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Truitt Joseph |
Director |
RSU 付与（制限付株式） |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-05-09 |
Hamilton Thomas Edward |
Director |
RSU 付与（制限付株式） |
8,300 |
$5.09 |
$42.25K |
8,300 |
| 2023-02-07 |
Shankar Gopi |
Officer |
不明 |
- |
- |
- |
- |
| 2023-02-07 |
Shankar Gopi |
Chief Development Officer |
RSU 付与（制限付株式） |
180,000 |
$5.88 |
$1.06M |
180,000 |
| 2023-01-31 |
Celano Michael |
Chief Financial Officer |
RSU 付与（制限付株式） |
76,000 |
- |
- |
107,746 |
| 2023-01-31 |
Ben-maimon Carole |
President and CEO |
RSU 付与（制限付株式） |
205,000 |
- |
- |
261,829 |
| 2022-09-16 |
Celano Michael |
Chief Financial Officer |
情報に基づく買い |
31,746 |
$3.15 |
$100K |
31,746 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
